Evidence map›Paper›PMID 24672751›Full record

ArticleStem cell reports2014

Engineered biomaterials control differentiation and proliferation of human-embryonic-stem-cell-derived cardiomyocytes via timed Notch activation.

Jason C Tung, Sharon L Paige, Buddy D Ratner, Charles E Murry, Cecilia M Giachelli

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Engineering Approaches to Study Cellular Decision Making.Annual review of biomedical engineering · 2018
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jason C TungDepartment of Bioengineering, University of Washington, Seattle, WA 98195, USA.
Sharon L PaigeDepartment of Pathology, University of Washington, Seattle, WA 98195, USA ; Center for Cardiovascular Biology, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.
Buddy D RatnerDepartment of Bioengineering, University of Washington, Seattle, WA 98195, USA.
Charles E MurryDepartment of Bioengineering, University of Washington, Seattle, WA 98195, USA ; Department of Pathology, University of Washington, Seattle, WA 98195, USA ; Department of Medicine/Cardiology, University of Washington, Seattle, WA 98195, USA ; Center for Cardiovascular Biology, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.
Cecilia M GiachelliDepartment of Bioengineering, University of Washington, Seattle, WA 98195, USA.
University of Washington · US

Funding

Self Renewal and Differentiation of Human Embryonic Stem CellsP01GM081619 · NIGMS · UNIVERSITY OF WASHINGTON · PI REH, THOMAS A · 2007 to 2017
$20.6M
Vascularization and Growth of Human Myocardial GraftsP01HL094374 · NHLBI · UNIVERSITY OF WASHINGTON · PI MINAMI, ELINA · 2010 to 2014
$14.5M
Engineered Cardiac Morphogenesis-Stem Cells and ScaffoldsR01HL064387 · NHLBI · UNIVERSITY OF WASHINGTON · PI RATNER, BUDDY D · 2006 to 2010
$10.2M
Expansion of cardiac and hematopoietic progenitors by Wnt and NotchU01HL100405 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI EPSTEIN, JONATHAN A., MORRISEY, EDWARD E · 2009 to 2015
$8.1M
Cell-Based Cardiac RepairR01HL084642 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E · 2007 to 2014
$4.9M
Bioengineering Cardiovascular Training GrantT32EB001650 · NIBIB · UNIVERSITY OF WASHINGTON · PI REGNIER, MICHAEL · 2004 to 2019
$3.6M
NHLBI NIH HHS P01 HL094374NHLBI NIH HHS R01 HL064387NHLBI NIH HHS R01 HL084642NHLBI NIH HHS U01 HL100405NIBIB NIH HHS T32 EB001650NIGMS NIH HHS P01 GM081619
6 · The paper itself

Abstract

For cell-based treatments of myocardial infarction, a better understanding of key developmental signaling pathways and more robust techniques for producing cardiomyocytes are required. Manipulation of Notch signaling has promise as it plays an important role during cardiovascular development, but previous studies presented conflicting results that Notch activation both positively and negatively regulates cardiogenesis. We developed surface- and microparticle-based Notch-signaling biomaterials that function in a time-specific activation-tunable manner, enabling precise investigation of Notch activation at specific developmental stages. Using our technologies, a biphasic effect of Notch activation on cardiac differentiation was found: early activation in undifferentiated human embryonic stem cells (hESCs) promotes ectodermal differentiation, activation in specified cardiovascular progenitor cells increases cardiac differentiation. Signaling also induces cardiomyocyte proliferation, and repeated doses of Notch-signaling microparticles further enhance cardiomyocyte population size. These results highlight the diverse effects of Notch activation during cardiac development and provide approaches for generating large quantities of cardiomyocytes.

Indexed as

Biocompatible MaterialsCell DifferentiationCalcium-Binding ProteinsCell-Derived MicroparticlesCell MembraneCell ProliferationEctodermEmbryonic Stem CellsFibrinGene Expression Regulation, DevelopmentalHumansIntercellular Signaling Peptides and ProteinsMembrane ProteinsMyocytes, CardiacReceptors, NotchSerrate-Jagged ProteinsBiocompatible MaterialsCalcium-Binding ProteinsFibrinIntercellular Signaling Peptides and ProteinsMembrane ProteinsReceptors, NotchSerrate-Jagged Proteins

Identifiers

PMID24672751
PMCPMC3964284
OpenAlexW2003957762

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.